Document is current

Article History

Received: 12 January 2026

Revised: 9 February 2026

Accepted: 11 February 2026

First Online: 19 February 2026

Declarations

:

: The authors have no relevant conflict of interest with respect to the contents of this manuscript. BBS has received honoraria for lectures from IPSEN, Merz, Abbvie, Medtronic, Orion Pharma, Ambu, Britannia; received honoraria for participating in Advisory Boards from IPSEN, Merz, Innoventa Medica, Abbvie and TEVA; received unconditional grants and funding for Investigator-initiated clinical trials from Merz, Ortbit Health, Britannia. JW has received honoraria for lectures from AbbVie, Ipsen, and Merz; has received honoraria for participating in Advisory Boards AbbVie, Ipsen, and Merz. RR contracted researches with the Michael J. Fox Foundation Genetics of Parkinson’s Disease, (GP2, monogenic and complex), with the University of Lubeck XDP Collaboration and with the University of Santo Tomas Research Center for Health Sciences. He participated in the advisory board with travel and lecture honoraria for Ipsen, Abbvie, Eisai, Otsuka Viatris, and Sun pharma. RReebye has received honoraria for participating in Advisory Boards from Ipsen, Abbvie, and Merz. JJ has received honoraria for participating in Advisory boards, lecturing, sponsored clinical research and peer training for Abbvie, Ipsen, and Merz pharmaceutical companies. GEF has received research grants from Abbvie, Merz, Ottobock, Revance Therapeutics, Saol Therapeutics. Done consulting for Abbvie, Ipsen, Lifeward, Merz, Saol Therapeutics. PS has received honoraria for lectures from IPSEN, Merz, Abbvie, Medtronic, Orion Pharma, Ambu, Britannia; has received honoraria for participating in Advisory Boards from IPSEN, Merz, Abbvie; has received unconditional grants and funding for Investigator-initiated clinical trials from Merz, Ortbit Health, Britannia. PE has received honoraria for lectures and hosting advisory board for IPSEN.